Probiotic effects on late-onset sepsis in very preterm infants: A randomized controlled trial

Pediatrics

Volumn 132, Issue 6, 2013, Pages 1055-1062

  Jacobs, Susan E ^a,b,c   Tobin, Jacinta M ^c   Opie, Gillian F ^c,d   Donath, Susan ^c,e   Tabrizi, Sepehr N ^c,f,g   Pirotta, Marie ^h   Morley, Colin J ^a,b   Garland, Suzanne M ^c,f,g  

^a Women's and Children's Health   (Australia)

^b Critical Care and Neurosciences Group   (Australia)

^c Department of Obstetrics and Gynaecology ^*  (Australia)

^d MERCY HOSPITAL FOR WOMEN   (Australia)

^e Clinical Epidemiology and Biostatistics Unit   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Infant Preterm; Necrotizing enterocolitis; Probiotics; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; MALTODEXTRIN; PLACEBO; PROBIOTIC AGENT; STEROID;

AUSTRALIA; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM LONGUM INFANTIS; BREAST FEEDING; CAUSE OF DEATH; CONTROLLED STUDY; CULTURE TECHNIQUE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GESTATION PERIOD; HUMAN; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NECROTIZING ENTEROCOLITIS; NEW ZEALAND; NONHUMAN; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEPSIS; STREPTOCOCCUS THERMOPHILUS; BIFIDOBACTERIUM; CLINICAL TRIAL; ENTEROCOLITIS, NECROTIZING; INFANT, PREMATURE, DISEASES; INTENTION TO TREAT ANALYSIS; MORTALITY; NEWBORN; STATISTICAL MODEL; TREATMENT OUTCOME;

BIFIDOBACTERIUM; DOUBLE-BLIND METHOD; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENTION TO TREAT ANALYSIS; LOGISTIC MODELS; MALE; PROBIOTICS; PROSPECTIVE STUDIES; SEPSIS; STREPTOCOCCUS THERMOPHILUS; TREATMENT OUTCOME;

EID: 84890700637     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1339     Document Type: Review

References (40)

1. Australian and New Zealand Neonatal Network. Report of the Australian and New Zealand Neonatal 2008 and 2009. Sydney: Australian and New Zealand Neonatal Network; 2012
2. Hornik CP, Fort P, Clark RH, et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev. 2012;88 (2 suppl 2):S69-S74
3. Schwiertz A, Gruhl B, Löbnitz M, Michel P, Radke M, Blaut M. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res. 2003;54(3):393-399
4. Mshvildadze M, Neu J, Shuster J, Theriaque D, Li N, Mai V. Intestinal microbial ecology in premature infants assessed with non-culturebased techniques. J Pediatr. 2010;156(1):20-25
5. Cotten CM, Taylor S, Stoll B, et al NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123(1):58-66
6. Gilliland S, Morelli L, Reid G. The World Health Organisation. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001. Available at: www.who.int/foodsafety/publications/ fs-management/en/probiotics. pdf. Accessed November 23, 2012
7. Shanahan F. Molecular mechanisms of probiotic action: it's all in the strains! Gut. 2011; 60(8):1026-1027
8. Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: An updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg. 2012;47(1):241-248
9. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010;125(5):921-930
10. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2011;(3):CD005496
11. Mihatsch WA, Braegger CP, Decsi T, et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr. 2012;31(1):6-15
12. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: A systematic review of randomized controlled trials. Lancet. 2007;369 (9573):1614-1620
13. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115(1):1-4
14. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing ARTICLenterocolitis in very low birth weight neonates. J Pediatr. 2005;147(2):192-196
15. Garland SM, Tobin JM, Pirotta M, et al; ProPrems Study Group. The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants. BMC Infect Dis. 2011;11:210
16. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based on clinical staging. Ann Surg. 1978;187(1):1-7
17. Walsh MC, Kliegman RM. Necrotizing enterocolitis: Treatment based on staging criteria. Pediatr Clin North Am. 1986;33(1):179-201
18. Abeywardana S. Australian and New Zealand Neonatal Network Annual Report 2003. Sydney: ANZNN; 2005
19. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002;82(2):103-108
20. Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: A randomized study. Clin Infect Dis. 2006;42(12):1735-1742
21. Lin HC, Hsu CH, Chen HL, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: A multicenter, randomized, controlled trial. Pediatrics. 2008;122(4):693-700
22. Rougé C, Piloquet H, Butel MJ, et al. Oral supplementation with probiotics in verylow- birth-weight preterm infants: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2009;89(6):1828-1835
23. Braga TD, da Silva GA, de Lira PI, de Carvalho Lima M. Efficacy of Bifidobacterium reve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: A double-blind, randomized, controlled trial. Am J Clin Nutr. 2011;93(1):81-86
24. Sari FN, Dizdar EA, Oguz S, Erdeve O, Uras N, Dilmen U. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: A andomized, controlled trial. Eur J Clin Nutr. 2011;65(4):434-439
25. Romeo MG, Romeo DM, Trovato L, et al. Role of probiotics in the prevention of the nteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and eurological outcome. J Perinatol. 2011;31(1):63-69
26. Chrzanowska-Liszewska D, Seliga-Siwecka J, Kornacka MK. The effect of actobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infants - double blinded randomized control trial. Early Hum Dev. 2012;88(1):57-60
27. Mihatsch WA, Vossbeck S, Eikmanns B, Hoegel J, Pohlandt F. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: A randomized controlled trial. Neonatology. 2010;98(2):156-163
28. Al-Hosni M, Duenas M, Hawk M, et al. Probiotics - supplemented feeding in extremely low-birth-weight infants. J Perinatol. 2012;32(4):253-259
29. Rojas MA, Lozano JM, Rojas MX, et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics. 2012;130(5). Available at: www. pediatrics.org/cgi/content/full/130/5/e1113
30. Stratiki Z, Costalos C, Sevastiadou S, et al. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev. 2007;83(9):575-579
31. Samanta M, Sarkar M, Ghosh P, Ghosh J, Sinha M, Chatterjee S. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr. 2009;55(2):128-131
32. Manzoni P, Rinaldi M, Cattani S, et al Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial. JAMA. 2009;302(13):1421-1428
33. Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2013;98(1):F5-F9
34. Garland SM, Jacobs SE, Tobin JM, Opie GF, Donath S; ProPrems study group. A cautionary note on instituting probiotics into routine clinical care for premature infants. ediatrics. 2010;126(3). Available at: www. pediatrics.org/cgi/content/full/126/3/e741, author reply e743-e745
35. Soll RF. Probiotics: Are we ready for routine use? Pediatrics. 2010;125(5):1071-1072
36. Neu J. Routine probiotics for premature infants: let's be careful! J Pediatr. 2011;158(4):672-674
37. Millar M, Wilks M, Fleming P, Costeloe K. Should the use of probiotics in the preterm be routine? Arch Dis Child Fetal Neonatal Ed. 2012;97(1):F70-F74
38. Jenke A, Ruf EM, Hoppe T, Heldmann M, Wirth S. Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy. Arch Dis Child Fetal Neonatal Ed. 2012;97(3):F217-F218
39. Ohishi A, Takahashi S, Ito Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr. 2010;156(4):679-681
40. Hickey L. The Intestinal Bacterial Community in the Preterm Infant. The University College of Dublin; 2012 [Doctor of Medicine in the College of Medicine & Medical Science]